Search by Drug Name or NDC

NDC 42291-0780-30 Rasagiline 1 mg/1 Details

Rasagiline 1 mg/1

Rasagiline is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AvKARE. The primary component is RASAGILINE MESYLATE.

MedlinePlus Drug Summary

Rasagiline is used alone or in combination with another medication to treat the symptoms of Parkinson's disease (a slowly progressing disease of the nervous system causing a fixed face without expression, tremor at rest, slowing of movements, walking with shuffling steps, stooped posture and muscle weakness). Rasagiline is in a class of medications called monoamine oxidase (MAO) type B inhibitors. It works by increasing the amounts of certain natural substances in the brain.

Related Packages: 42291-0780-30
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Rasagiline

Product Information

NDC	42291-0780
Product ID	42291-780_0993a1f0-3792-f9aa-e063-6294a90a0960
Associated GPIs	73300025200330
GCN Sequence Number	059121
GCN Sequence Number Description	rasagiline mesylate TABLET 1 MG ORAL
HIC3	H6A
HIC3 Description	ANTIPARKINSONISM DRUGS,OTHER
GCN	24654
HICL Sequence Number	032911
HICL Sequence Number Description	RASAGILINE MESYLATE
Brand/Generic	Generic
Proprietary Name	Rasagiline
Proprietary Name Suffix	n/a
Non-Proprietary Name	Rasagiline
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	1
Active Ingredient Units	mg/1
Substance Name	RASAGILINE MESYLATE
Labeler Name	AvKARE
Pharmaceutical Class	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]
DEA Schedule	n/a
Marketing Category	NDA AUTHORIZED GENERIC
Application Number	NDA021641
Listing Certified Through	2024-12-31

Package

NDC 42291-0780-30 (42291078030)

Pricing Information	N/A
NDC Package Code	42291-780-30
Billing NDC	42291078030
Package	30 TABLET in 1 BOTTLE (42291-780-30)
Marketing Start Date	2021-05-20
NDC Exclude Flag	N